Ecovyst Inc. (ECVT)

On our desk, the transition of Ecovyst into a pure-play sulfuric acid provider has completely reshaped the valuation narrative. Divesting the Advanced Materials and Catalysts business and deploying $465 million to pay down debt set a clean slate. With Q2 2026 sales surging 42% to $250.0 million and adjusted EBITDA hitting $53.1 million, the market is starting to reprice the streamlined operating model. KeyBanc moving its price target to $14 confirms that institutional conviction is building around this pure-play structural shift.

From a risk management standpoint, we are monitoring the net debt leverage ratio, which ticked up to 2.0 times at the end of Q2 2026 from 1.2 times due to the debt-funded Calabrian acquisition. While management expects the sulfur dioxide business to contribute $10 million to $12 million of second-half adjusted EBITDA and deliver $3 million to $4 million in synergies, the sudden leverage expansion introduces short-term vulnerability if industrial demand softens or sulfur pass-through costs face friction.

Watching the fundamental drivers, the organic volume growth in both regeneration and virgin sulfuric acid is impressive. High refinery utilization and favorable alkylation economics during the summer driving season provided a powerful tailwind for regeneration volumes. Meanwhile, virgin sulfuric acid rose double digits, bolstered by mining demand and the Waggaman asset contribution. Raising full-year sales guidance to a range of $1.02 billion to $1.06 billion shows management's high visibility into these demand pillars.

Our quantitative model flags the heavy reliance on sulfur-cost pass-throughs as a double-edged sword. With projected sulfur-cost pass-throughs adding roughly $220 million for the year, top-line revenue is heavily dictated by raw commodity cost volatility rather than purely organic volume expansion. While adjusted EBITDA protects underlying profitability, analysts must carefully separate pass-through inflation from true operational margin expansion when evaluating long-term cash generation.

As a hedge fund portfolio manager, I find the timing of the Calabrian acquisition particularly compelling. Integrating an immediately accretive asset right after the Technip Energies transaction proves management's aggressive capital allocation playbook. Generating $13 million in adjusted free cash flow for the first half of 2026 validates that the pure-play transformation is already spitting out cash, providing ample room to service the newly acquired debt without stressing liquidity.